Janux Therapeutics, Inc. JANX
NASDAQ · United States · Health Technology
$17.00+0.04 (+0.24%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.35 | -0.25 | -39.3% | $10.27M | -46.2% | -0.9%$16.00→$15.85 |
| Q1 2026 | 2026-05-07 | -0.39 | -0.50 | +22.0% | — | — | -3.0%$14.62→$14.18 |
| Q4 2025 | 2026-02-26 | -0.51 | -0.65 | +21.5% | — | — | -0.7%$13.70→$13.61 |
| Q3 2025 | 2025-11-06 | -0.39 | -0.60 | +35.0% | — | — | -3.8%$27.54→$26.48 |
| Q4 2023 | 2024-03-08 | -0.25 | -0.39 | +35.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.